^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

ZW220

i
Other names: ZW220
News
Trials
Company:
Zymeworks
Drug class:
Topoisomerase I inhibitor, NaPi2b-targeted antibody-drug conjugate
Related drugs:
News
Trials